Health Products Regulatory Authority
The Health Products Regulatory Authority is Ireland's statutory national regulator for human and veterinary medicines, medical devices, cosmetics, blood, tissues and cells, organs, and controlled drugs, providing authorisation, surveillance, pharmacovigilance, and enforcement integrated with EU regulatory networks.
- Company typePrivate
- Founded1996
- HeadquartersDublin, Ireland
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Health Products Regulatory Authority does
The Health Products Regulatory Authority (HPRA) is Ireland's national statutory regulatory authority for health products, established in 1996 to succeed the Irish Medicines Board. Its mandate covers the authorisation, surveillance, and enforcement of human medicines, veterinary medicines, medical devices, cosmetics, blood, blood components, tissues and cells, organs for transplantation, controlled drugs (including medical cannabis), precursor chemicals, and scientific animal protection. HPRA operates as the sole competent authority designated under Irish and EU legislation, serving as Ireland's single national point of contact for regulatory matters with direct linkage to EU-wide evaluation procedures (centralised EMA procedure, mutual recognition procedure, and decentralised procedure).
Its core operating technology comprises the Union Product Database (UPD) for veterinary variation notifications and SPC updates, a sampling and analysis programme handling over 400 samples per year (with approximately 75% routed for laboratory physiochemical, microbiological, and biological testing and the balance assessed for product-information compliance), and an electronic submission / online contact portal supporting scientific advice, application submissions, adverse-reaction reporting, and compliance queries. Beyond these systems, HPRA delivers a broad regulatory service catalogue spanning marketing authorisation, pharmacovigilance, labelling and distribution oversight, clinical trial and clinical investigation oversight, shortage management, risk-based recall coordination, and an Innovation Office providing product classification guidance for novel health products.
HPRA is funded through a combination of Irish government appropriations and fee-for-service charges on regulated activities (marketing authorisation applications, variations, clinical trials, manufacturing licences, export certification, and other services). It operates at arm's length from government while remaining accountable to the Minister for Health and the Minister for Agriculture, Food and the Marine. Headquartered at Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, with a workforce of 101-250 employees, HPRA is led by Chief Executive Officer Lorraine Nolan. Strategic posture centres on EU regulatory integration, post-Brexit bilateral cooperation with the UK VMD, antimicrobial and antiparasitic resistance monitoring via ESVAC, and enforcement against illegal health products reaching the Irish market.
Health Products Regulatory Authority firmographics
Firmographics- Name
- Health Products Regulatory Authority
- Legal name
- Health Products Regulatory Authority
- Website
- https://hpra.ie
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- The Health Products Regulatory Authority is Ireland's statutory national regulator for human and veterinary medicines, medical devices, cosmetics, blood, tissues and cells, organs, and controlled drugs, providing authorisation, surveillance, pharmacovigilance, and enforcement integrated with EU regulatory networks.
- Ownership category
- akta.pro rank
Health Products Regulatory Authority industry classification
Industry- Product category
- Pharmaceutical and Health Products Regulatory Services
- NAICS
- Administration of Public Health Programs (923120), Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (92615)
- akta.pro primary industry
- Drug Regulators (Human Pharmaceuticals) (HLAJADAA)
- akta.pro secondary industries
- Medical Device Regulators (HLAJADAC), Veterinary Regulatory Authorities (Licensing, Compliance & Enforcement) (HLAMAJAC), Clinical Trials Authorization & Oversight (GCP) (HLAJADAF), Controlled Substances & Pharmacy Regulation Authorities (HLAJACAI), Health Regulation, Licensing & Compliance (Public Health) (BPAIAJAN)
Keywords
Where Health Products Regulatory Authority is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
Health Products Regulatory Authority business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Others
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Standard marketing authorisation fees for veterinary medicines |
| Other | Multi-year contract | Service Item fee category for minor use veterinary medicines |
Distribution channels4 records
Marketing channels7 records
Health Products Regulatory Authority product offering
Product offeringCore offering
The Health Products Regulatory Authority (HPRA) is Ireland's statutory regulatory body that authorises, monitors, and enforces compliance for human and veterinary medicines, medical devices, cosmetics, blood, tissues and cells, organs, controlled drugs, and precursor chemicals. It grants marketing authorisations, conducts safety surveillance, issues safety notices, oversees clinical trials, and operates a sampling and analysis programme of more than 400 medicines annually in line with EU and Irish legislation.
Product overview
HPRA (Health Products Regulatory Authority) is Ireland's regulatory body for health products, operating as a single unified regulatory authority rather than a platform-plus-modules architecture. The organisation provides regulatory services across multiple sectors including human medicines, veterinary medicines, medical devices, cosmetics, blood, tissues and cells, organs, controlled drugs, and precursor chemicals. Key services include marketing authorisation, safety monitoring, quality surveillance, clinical trials oversight, adverse event reporting, and regulatory guidance through services like the Innovation Office and My Alerts subscription system. The HPRA enforces EU regulations including Regulation 2019/6 for veterinary medicines and collaborates with European regulatory networks.
Differentiator
Problem solved
Functional benefit
Products and services
- Marketing Authorisation for Human Medicines
- Marketing Authorisation for Veterinary Medicines
- Medical Devices Regulation
- Clinical Trials Oversight (CTIS)
- Cosmetics Regulation
- Sampling and Analysis Programme
- Blood, Tissues, Cells and Organs Regulation
- Controlled Drugs and Precursor Chemicals Regulation
- Scientific Animal Protection Regulation
- Innovation Office and Classification Services
Quantifiable outcome
- Enforcement action resulting in seizure of nearly 7,000 illegal teeth whitening products
- +2 more outcomes
Companies that use Health Products Regulatory Authority
Customer profileSegments5 records
Ideal customer profiles5 records
Health Products Regulatory Authority technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Health Products Regulatory Authority partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and major.
- Department of Agriculture, Food and the Marine (DAFM)coreThe DAFM is the competent authority for regulating the purchase, supply, use, and importation of veterinary medicines in Ireland. HPRA consults with DAFM on veterinary clinical trial applications and collaborates on cascade provisions for exceptional use of medicines.
- Official Medicines Control Laboratory Network (OMCL)coreHPRA is an active member of this EU network of laboratories which ensures surveillance testing activities deliver maximum meaningful surveillance information, makes best use of available resources, ensures collaborative approach to testing, and encourages information sharing.
- European Medicines Agency (EMA)coreHPRA participates in evaluation of applications submitted for central authorisation to EMA and contributes to EU-wide pharmacovigilance, maximum residue limit (MRL) evaluations, and antimicrobial resistance monitoring through ESVAC programme.
- Heads of Medicines Agencies (HMA)coreHPRA collaborates with HMA at European level to improve availability of veterinary medicines through joint evaluation initiatives and coordinated regulatory actions.
- UK Veterinary Medicines Directorate (VMD)majorHPRA and VMD have established joint-labelling procedures allowing single labels/leaflets agreed by both authorities for products marketed in Ireland and the UK. This maintains product availability despite Brexit challenges.
- Health and Safety Executive (HSE)majorHSE is responsible for gathering information on antimicrobial consumption for human use through the European Surveillance of Antimicrobial Consumption (ESAC) programme, with HPRA gathering similar data for veterinary antimicrobials through ESVAC.
- European Directorate for the Quality of Medicines & HealthCare (EDQM)coreHPRA carries out surveillance activities forming part of EU surveillance coordinated by EDQM, contributing to pan-European quality assurance of medicines.
- Food Safety Authority of IrelandmajorCollaborates with HPRA on residue testing of food products including milk, honey, eggs, and meat under the national residue plan, ensuring food safety from veterinary medicine residues.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Health Products Regulatory Authority competitors and assessment
Company assessmentDirect peers
- Medicines and Healthcare products Regulatory Agency (MHRA): The UK's regulator for medicines, medical devices and blood components, operating under statutory authority. MHRA is HPRA's most direct peer, with an established joint-labelling procedure and parallel regulatory functions across human and veterinary medicines.
- Federal Institute for Drugs and Medical Devices (BfArM): Germany's federal regulator for human medicines and medical devices. BfArM regularly acts as Reference Member State in EU DCP/MRP procedures and is a comparable peer for any company operating in EU centralised authorisations.
- Agence nationale de sécurité du médicament (ANSM): France's national medicines regulator. ANSM regulates medicines, medical devices and cosmetics at national level, performing marketing authorisations, pharmacovigilance and inspections comparable to HPRA's mandate.
- Spanish Agency of Medicines and Medical Products (AEMPS): Spain's national competent authority for medicines, medical devices and cosmetics. AEMPS is a peer in EU decentralised procedures and operates sampling, surveillance and pharmacovigilance systems similar to HPRA's.
- Austrian Medicines and Medical Devices Agency (AGES MEA): Austria's medicines and medical devices regulator. Similar mid-sized national authority in the EU network with comparable scope over human and veterinary medicines.
- Dutch Medicines Evaluation Board (CBG-MEB): The Netherlands' medicines regulator for human and veterinary products. CBG-MEB participates in EU DCP/MRP procedures and has a similar scope of fee-based regulatory services.
- UK Veterinary Medicines Directorate (VMD): UK's specialist veterinary medicines regulator that HPRA partners with under a joint-labelling procedure post-Brexit. Functionally a peer in the veterinary regulatory sphere where HPRA has the strongest non-EU linkage.
Broad incumbents
- European Medicines Agency (EMA): The EU-level regulator that grants centralised marketing authorisations across all member states. EMA is HPRA's umbrella authority for centralised procedures and a key partner, though it is a supranational agency rather than a national competent authority.
- U.S. Food and Drug Administration (FDA): The US federal regulator for drugs, biologics, medical devices and cosmetics. FDA is much larger but functionally the closest analogue in scope and statutory authority to HPRA's combined human/vet/medical device remit.
Regional players
- Therapeutic Goods Administration (TGA, Australia): Australia's regulator for medicines, medical devices and other therapeutic goods. Comparable in remit and statutory authority, but operating under a non-EU framework outside HPRA's geographic scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Health Products Regulatory Authority social profiles
Digital presenceHealth Products Regulatory Authority financial estimates
Financial estimateRevenue estimate
Valuation estimate
Health Products Regulatory Authority leadership team
Management profileNumber of profiles
Profiles2 records
Health Products Regulatory Authority funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Health Products Regulatory Authority M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Health Products Regulatory Authority
What does Health Products Regulatory Authority do?
The Health Products Regulatory Authority (HPRA) is Ireland's statutory regulatory body that authorises, monitors, and enforces compliance for human and veterinary medicines, medical devices, cosmetics, blood, tissues and cells, organs, controlled drugs, and precursor chemicals. It grants marketing authorisations, conducts safety surveillance, issues safety notices, oversees clinical trials, and operates a sampling and analysis programme of more than 400 medicines annually in line with EU and Irish legislation.
Is Health Products Regulatory Authority a public or private company?
Health Products Regulatory Authority is a private company. It is classified as state government owned and is currently operating.
When was Health Products Regulatory Authority founded?
Health Products Regulatory Authority was founded in 1996. It employs 101 to 250 people.
Where is Health Products Regulatory Authority based?
Health Products Regulatory Authority is headquartered in Dublin, Ireland, in the Europe region.
Who are Health Products Regulatory Authority's main competitors?
Direct peers on record are Medicines and Healthcare products Regulatory Agency (MHRA), Federal Institute for Drugs and Medical Devices (BfArM), Agence nationale de sécurité du médicament (ANSM), Spanish Agency of Medicines and Medical Products (AEMPS), Austrian Medicines and Medical Devices Agency (AGES MEA), Dutch Medicines Evaluation Board (CBG-MEB) and UK Veterinary Medicines Directorate (VMD). Broad incumbents are European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA). Therapeutic Goods Administration (TGA, Australia) is listed as a regional player.
Does Health Products Regulatory Authority have an API?
No public API is recorded for Health Products Regulatory Authority.
What industry is Health Products Regulatory Authority in?
Health Products Regulatory Authority's product category is Pharmaceutical and Health Products Regulatory Services. Its primary akta.pro industry code is HLAJADAA, Drug Regulators (Human Pharmaceuticals), with a secondary code of HLAJADAC, Medical Device Regulators. Its NAICS code is 923120.